Recorded: 14 May 2004
Oh, the nearest future is to turn the investigation of these diseases from an empirical art into a very precise digitized science. We will be able to take individuals and be able to understand their gene variations that contribute to the disease and map very precisely all the phenotypic events that result from those genetic changes. We begin to understand a Swiss watch. We’ll understand how the parts in this case give rise to that disease part.
Richard A. Gibbs is currently the Director of the Human Genome Sequencing Center at Baylor College of Medicine (BCM) and the Wofford Cain Professor in the Department of Molecular and Human Genetics. He received a B.Sc. (Hons) in 1979 and a Ph.D. in Genetics and Radiation Biology in 1985 at the University of Melbourne in Australia. In 1990 he completed a postdoctoral fellowship at Houston’s Baylor College of Medicine, studying the molecular basis of human X-linked diseases and developing technologies for rapid genetic analysis. He developed several fundamental technologies for nucleic acid analysis. In 1991, he joined the BCM faculty and played a key role in the early planning and development phases of the Human Genome Project. In 1996, he established the BCM Human Genome Sequencing Center when Baylor was chosen as one of six programs to complete the final phase of the Human Genome Project. Dr. Gibbs has also made significant contributions to the deciphering of the fly, mouse, dictyostelium, and rat genomes. Among the numerous awards and honors received by Dr. Gibbs, he was awarded the Michael E. DeBakey, M.D., Excellence in Research Award in 2000.